Proteome Sciences PLC Appointment of Nominated Adviser and Broker (0381L)
December 20 2018 - 1:01AM
UK Regulatory
TIDMPRM
RNS Number : 0381L
Proteome Sciences PLC
20 December 2018
20 December 2018
Proteome Sciences plc
(the "Company")
Appointment of Nominated Adviser and Broker
The Board of Proteome Sciences plc is pleased to announce that
Allenby Capital Limited has been appointed as the Company's new
Nominated Adviser and sole Broker with immediate effect.
For further information please contact:
Proteome Sciences plc
Dr Jeremy Haigh, Chief Executive Officer Tel: +44 (0)20 7043 2116
Dr Ian Pike, Chief Scientific Officer
Richard Dennis, Chief Commercial Officer
Allenby Capital Limited (Nominated Adviser & Broker)
John Depasquale / Jeremy Porter Tel: +44 (0) 20 3328 5656
About Proteome Sciences plc. (www.proteomics.com)
Proteome Sciences plc is a specialist provider of contract
proteomics services to enable drug discovery, development and
biomarker identification, and employs proprietary workflows for the
optimum analysis of tissues, cells and body fluids. SysQuant(R) and
TMT(R)MS2 are unbiased methods for identifying and contextualising
new targets and defining mechanisms of biological activity, while
analysis using Super-Depletion and TMTcalibrator(TM) provides
access to over 8,500 circulating plasma proteins for the discovery
of disease-related biomarkers. Targeted assay development using
mass spectrometry delivers high sensitivity, interference-free
biomarker analyses in situations where standard ELISA assays are
not available.
The Company has its headquarters in London, UK, with laboratory
facilities in Frankfurt, Germany.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
APPTLBRTMBTBBJP
(END) Dow Jones Newswires
December 20, 2018 02:01 ET (07:01 GMT)
Proteome Sciences (LSE:PRM)
Historical Stock Chart
From Mar 2024 to Apr 2024
Proteome Sciences (LSE:PRM)
Historical Stock Chart
From Apr 2023 to Apr 2024